Literature DB >> 19131897

CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA.

Chris Verhofstede1, Linos Vandekerckhove, Veerle Van Eygen, Els Demecheleer, Ina Vandenbroucke, Bart Winters, Jean Plum, Dirk Vogelaers, Lieven Stuyver.   

Abstract

OBJECTIVE: To compare the distribution of R5-like and X4-like HIV-1 envelope sequences in plasma and peripheral blood mononuclear cell (PBMC).
METHODS: Clonal sequencing of the HIV-1 glycoprotein 120 region was performed on PBMC DNA and plasma RNA of 11 HIV-1 subtype B-infected patients with high probability of carrying X4 virus. Coreceptor use was predicted using the position-specific scoring matrix (PSSM).
RESULTS: A total of 330 and 427 clonal envelope sequences were obtained from PBMC and plasma, respectively. PSSM interpretation revealed the presence of a mixture of predicted X4 and R5 sequences in 10 patients and pure R5 sequences in 1. The X4 sequences were significantly more represented in PBMC (with an average of 52.2% of the clonal proviral sequences scored X4) compared with plasma (19.7% X4 sequences) (P < 0.0001). At the single patient level, the higher representation of X4 sequences in PBMC reached statistical significance (P < 0.002) in 6 individuals.
CONCLUSIONS: Mixtures of X4 and R5 sequences with highly divergent PSSM scores are present in both plasma and PBMC, but a shift toward a more abundant representation of X4-like PSSM scores in PBMC-derived DNA was apparent. Additional studies are needed to evaluate the clinical importance of these findings with regard to tropism prediction and the use of CCR5 antagonists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131897     DOI: 10.1097/QAI.0b013e31819118fa

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Liliana Elena Weimer; Maria Franca Pirillo; Anna Volpe; Alessandra Mercuri; Albertina Cavalli; Vincenzo Fragola; Laura Monno; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Raffaella Bucciardini; Marco Floridia
Journal:  J Antimicrob Chemother       Date:  2012-02-23       Impact factor: 5.790

2.  HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Authors:  Cécile Tremblay; Isabelle Hardy; Richard Lalonde; Benoit Trottier; Irina Tsarevsky; Louis-Philippe Vézina; Michel Roger; Mark Wainberg; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent.

Authors:  Mariangela Cavarelli; Lara Mainetti; Angela Rosa Pignataro; Alba Bigoloni; Monica Tolazzi; Andrea Galli; Silvia Nozza; Antonella Castagna; Michela Sampaolo; Enzo Boeri; Gabriella Scarlatti
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

4.  HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects.

Authors:  S G Parisi; C Andreoni; L Sarmati; C Boldrin; A R Buonomini; S Andreis; R Scaggiante; M Cruciani; O Bosco; V Manfrin; G d'Ettorre; C Mengoli; V Vullo; G Palù; M Andreoni
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

5.  Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia.

Authors:  Lavinia Fabeni; Giulia Berno; Valentina Svicher; Francesca Ceccherini-Silberstein; Caterina Gori; Ada Bertoli; Cristina Mussini; Miriam Lichtner; Mauro Zaccarelli; Adriana Ammassari; Carmela Pinnetti; Stefania Cicalini; Claudio Maria Mastroianni; Massimo Andreoni; Andrea Antinori; Carlo Federico Perno; Maria Mercedes Santoro
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

6.  TROCAI (tropism coreceptor assay information): a new phenotypic tropism test and its correlation with Trofile enhanced sensitivity and genotypic approaches.

Authors:  Alejandro Gonzalez-Serna; Manuel Leal; Miguel Genebat; Maria Antonia Abad; Antonio Garcia-Perganeda; Sara Ferrando-Martinez; Ezequiel Ruiz-Mateos
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

7.  Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.

Authors:  Marion Cornelissen; Edwin J Heeregrave; Fokla Zorgdrager; Georgios Pollakis; William A Paxton; Antoinette C van der Kuyl
Journal:  Arch Virol       Date:  2010-09-24       Impact factor: 2.574

8.  Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

Authors:  Edwin J Heeregrave; Mark J Geels; Jason M Brenchley; Elly Baan; David R Ambrozak; Renee M van der Sluis; Rune Bennemeer; Daniel C Douek; Jaap Goudsmit; Georgios Pollakis; Richard A Koup; William A Paxton
Journal:  Virology       Date:  2009-08-20       Impact factor: 3.616

9.  Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study.

Authors:  Elise Tu; Luke C Swenson; Sally Land; Sarah Pett; Sean Emery; Kat Marks; Anthony D Kelleher; Steve Kaye; Rolf Kaiser; Eugene Schuelter; Richard Harrigan
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

10.  Longitudinal HIV-1 gp120-C2V3C3 phylogenetic surveillance and tropism evolution in patients under HAART.

Authors:  Franco A Moretti; Manuel Gómez-Carrillo; Jorge F Quarleri
Journal:  Virus Genes       Date:  2013-03-06       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.